Integrative multi-omic analysis reveals conserved cell-projection deficits in human Down syndrome brains.

Down syndrome RNA-binding proteins alternative splicing axonogenesis cell projection miRNA neurodevelopment neuronal polarization proteomics transcriptomics

Journal

Neuron
ISSN: 1097-4199
Titre abrégé: Neuron
Pays: United States
ID NLM: 8809320

Informations de publication

Date de publication:
21 May 2024
Historique:
received: 02 01 2023
revised: 17 03 2024
accepted: 01 05 2024
medline: 30 5 2024
pubmed: 30 5 2024
entrez: 29 5 2024
Statut: aheadofprint

Résumé

Down syndrome (DS) is the most common genetic cause of cognitive disability. However, it is largely unclear how triplication of a small gene subset may impinge on diverse aspects of DS brain physiopathology. Here, we took a multi-omic approach and simultaneously analyzed by RNA-seq and proteomics the expression signatures of two diverse regions of human postmortem DS brains. We found that the overexpression of triplicated genes triggered global expression dysregulation, differentially affecting transcripts, miRNAs, and proteins involved in both known and novel biological candidate pathways. Among the latter, we observed an alteration in RNA splicing, specifically modulating the expression of genes involved in cytoskeleton and axonal dynamics in DS brains. Accordingly, we found an alteration in axonal polarization in neurons from DS human iPSCs and mice. Thus, our study provides an integrated multilayer expression database capable of identifying new potential targets to aid in designing future clinical interventions for DS.

Identifiants

pubmed: 38810652
pii: S0896-6273(24)00329-5
doi: 10.1016/j.neuron.2024.05.002
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests L.C. is cofounder/scientific consultant at IAMA Therapeutics. L.C. and A.C. are inventors on patents US9,822,368, EP3083959, JP6490077; US11427836; and IT102019000004929.

Auteurs

Mohit Rastogi (M)

Brain Development and Disease Laboratory, Istituto Italiano di Tecnologia, Genova 16163, Italy.

Martina Bartolucci (M)

Core Facilities - Clinical Proteomics and Metabolomics, IRCCS Istituto Giannina Gaslini, Genova 16147, Italy.

Marina Nanni (M)

Brain Development and Disease Laboratory, Istituto Italiano di Tecnologia, Genova 16163, Italy.

Michelangelo Aloisio (M)

Central RNA Laboratory, Istituto Italiano di Tecnologia, Genova 16152, Italy.

Diego Vozzi (D)

Central RNA Laboratory, Istituto Italiano di Tecnologia, Genova 16152, Italy.

Andrea Petretto (A)

Core Facilities - Clinical Proteomics and Metabolomics, IRCCS Istituto Giannina Gaslini, Genova 16147, Italy.

Andrea Contestabile (A)

Brain Development and Disease Laboratory, Istituto Italiano di Tecnologia, Genova 16163, Italy. Electronic address: andrea.contestabile@iit.it.

Laura Cancedda (L)

Brain Development and Disease Laboratory, Istituto Italiano di Tecnologia, Genova 16163, Italy; Dulbecco Telethon Institute, Rome 00185, Italy. Electronic address: laura.cancedda@iit.it.

Classifications MeSH